HEPA

Hepion Pharmaceuticals
HEPA

Delisted

HEPA was delisted on the 12th of May, 2025.

Back to rankings

5 hedge funds and large institutions have $2.49M invested in Hepion Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$446K
2
+$187K

Top Sellers

1
-$126K
2
-$105K
3
-$78K
4
Northern Trust
Northern Trust
Illinois
-$57K
5
Morgan Stanley
Morgan Stanley
New York
-$37K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$933K
2
$446K
3
$374K
4
$113K
5
$106K
6
$72K
7
$65K
8
$57K
9
$54K
10
$52K
11
$39K
12
$36K
13
$26K
14
$26K
15
$22K
16
$18K
17
$13K
18
$10K
19
$8K
20
$5K
21
$5K
22
$4K
23
$4K
24
$2K
25
$1K
1
2